| #37 |
Alison Margaret Anne Bennett |
E.I. Du Pont De Nemours And |
2 |
| #37 |
John Grosspietsch |
Motorola |
2 |
| #37 |
Edmund Arthur Flexman |
E.I. Du Pont De Nemours And |
2 |
| #37 |
Claudia Schultze |
E.I. Du Pont De Nemours And |
2 |
| #37 |
Richard Arhart |
E.I. Du Pont De Nemours And |
2 |
| #37 |
Rick W. Ye |
E.I. Du Pont De Nemours And |
2 |
| #37 |
Steven Dale Ittel |
E.I. Du Pont De Nemours And |
2 |
| #37 |
Roger Harquail French |
E.I. Du Pont De Nemours And |
2 |
| #37 |
Fred L. Ferguson |
Ta Instruments-Waters |
2 |
| #37 |
Qiong Cheng |
E.I. Du Pont De Nemours And |
2 |
| #37 |
Christopher F. Carney |
Ta Instruments-Waters |
2 |
| #37 |
Gary Steelman |
Astrazeneca Ab |
2 |
| #37 |
Qianqiu (Christine) Ye |
Rodel Holdings |
2 |
| #37 |
Orn Adalsteinsson |
Arkion Life Sciences |
2 |
| #37 |
Diana Lynn Klug |
E.I. Du Pont De Nemours And |
2 |
| #37 |
Theodore A. Koch |
E.I. Du Pont De Nemours And |
2 |
| #37 |
Cynthia J. Slomowitz |
— |
2 |
| #37 |
Charles Brandenburg |
E.I. Du Pont De Nemours And |
2 |
| #37 |
Joseph Cacciola |
Bristol-Myers Squibb |
2 |
| #37 |
Joseph W. Jackson |
Southco |
2 |
| #37 |
Thomas P. Maduskuie, Jr. |
Incyte |
2 |
| #37 |
Ray Yin |
Anp Technologies |
2 |
| #37 |
Garret D. Figuly |
E.I. Du Pont De Nemours And |
2 |
| #37 |
Paul Joseph Fagan |
E.I. Du Pont De Nemours And |
2 |
| #37 |
Velliyur Nott Mallikarjuna Rao |
E.I. Du Pont De Nemours And |
2 |
| #37 |
Peisheng Sheng |
Agilent Technologies |
2 |
| #37 |
Dudley W. C. Spencer |
Denco |
2 |
| #37 |
Jennie Shen |
E.I. Du Pont De Nemours And |
2 |
| #37 |
Fredrick Claus Zumsteg, Jr. |
E.I. Du Pont De Nemours And |
2 |
| #37 |
Howard M. Blank |
E.I. Du Pont De Nemours And |
2 |
| #37 |
Mohand Melbouci |
Hercules |
2 |
| #37 |
Barry A. Springer |
3-Dimensional Pharmaceuticals |
2 |
| #37 |
Jeffery Scott Thompson |
E.I. Du Pont De Nemours And |
2 |
| #37 |
Roy Vore |
Arch Chemicals |
2 |
| #85 |
Hanxing Zheng |
Elsicon |
1 |
| #85 |
Stephen Bass |
HP |
1 |
| #85 |
Karen Marie Bloch |
E.I. Du Pont De Nemours And |
1 |
| #85 |
Kathryn A. Pearlstine |
E.I. Du Pont De Nemours And |
1 |
| #85 |
Fuqiang Jin |
Dupont Pharmaceuticals |
1 |
| #85 |
Michael K. Hanafey |
E.I. Du Pont De Nemours And |
1 |
| #85 |
Edward Vacek |
Astrazeneca Ab |
1 |
| #85 |
Matthew Jeffries |
Bristol-Myers Squibb |
1 |
| #85 |
Samuel Blumberg |
— |
1 |
| #85 |
Frank J. Weigert |
E.I. Du Pont De Nemours And |
1 |
| #85 |
Christopher D. Mc Clung |
Bristol-Myers Squibb |
1 |
| #85 |
Frank W. Hobbs, Jr. |
E.I. Du Pont De Nemours And |
1 |
| #85 |
Phil Bucay |
Agilent Technologies |
1 |
| #85 |
Paul A. Silver |
Hercules |
1 |
| #85 |
Andrew Maynard |
US Dept of Health & Human Services |
1 |
| #85 |
Drew Van Dyk |
E.I. Du Pont De Nemours And |
1 |